Market Value2,376,271,000
Total Holdings66
File Date2014-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRGO / Perrigo Company plc
GEVA / Synageva Biopharma Corp
AKRX / Akorn, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
NPSP / NPS Pharmaceuticals Inc
RLYP / Relypsa, Inc.
RNA / Avidity Biosciences, Inc.
XLRN / Acceleron Pharma Inc
SESN / Sesen Bio Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
CLVS / Clovis Oncology Inc
02318X100 / Ambit Biosciences Corp
AMPH / Amphastar Pharmaceuticals, Inc.
IMDZ / Immune Design Corp.
ALDR / Alder BioPharmaceuticals, Inc.
TBPH / Theravance Biopharma, Inc.
WMGIZ / Wright Medical Group N.V.
MDVN / Medivation, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
ANTH / Anthera Pharmaceuticals, Inc.
INVA / Innoviva, Inc.
WX / Wuxi Pharmatech (Cayman) Inc.
91911K102 / Bausch Health Companies
SGNT / Sagent Pharmaceuticals, Inc.
HTWR / Heartware International Inc.
KERX / Keryx Biopharmaceuticals, Inc.
G0083B108 / Actavis
ICPT / Intercept Pharmaceuticals Inc
INGN / Inogen, Inc.
COV /
SHPG / Shire Plc.
OMED / OptMed Inc
PRQR / ProQR Therapeutics N.V.
KPTI / Karyopharm Therapeutics Inc.
CELG / Celgene Corp.
018490100 / Allergan plc
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
FOLD / Amicus Therapeutics, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
0PP / Portola Pharmaceuticals Inc
ALGN / Align Technology, Inc.
CMRX / Chimerix, Inc.
US00C4U1L353 / Mylan N.V.
SGEN / Seagen Inc
MNKKQ / Mallinckrodt Plc
DXCM / DexCom, Inc.
TNDM / Tandem Diabetes Care, Inc.
ARAY / Accuray Incorporated
CBAY / CymaBay Therapeutics, Inc.
NXTM / NxStage Medical, Inc.
UTHR / United Therapeutics Corporation
MRK / Merck & Co., Inc.
BMRN / BioMarin Pharmaceutical Inc.
IMGN / ImmunoGen, Inc.
HALO / Halozyme Therapeutics, Inc.
AMGN / Amgen Inc.
BSX / Boston Scientific Corporation
ILMN / Illumina, Inc.
GILD / Gilead Sciences, Inc.
CI / The Cigna Group
TMO / Thermo Fisher Scientific Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
VRTX / Vertex Pharmaceuticals Incorporated
ISRG / Intuitive Surgical, Inc.
ABBV / AbbVie Inc.
PTCT / PTC Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
BIIB / Biogen Inc.
INCY / Incyte Corporation
PFE / Pfizer Inc.